ASCO Breakthrough is an annual Asia-Pacific oncology meeting offering novel research and expert, multidisciplinary perspectives on the newest scientific findings, clinical and technology advances, and treatment approaches that are rapidly changing cancer care. Take part in insightful sessions, case discussions, and abstract presentations, and join a community of like-minded professionals to contribute, together, toward conquering cancer.
Why Attend ASCO Breakthrough?
- Access Global Science with Regional Perspectives
- Connect with the Global ASCO Community in Asia
- Gain Insight to Enhance Your Clinical Practice
Program Overview
Sessions will cover a range of topics, including:
- Confronting the Global Surge of Early-Onset Cancers
- A Discussion on What It Will Take to Make Clinical Artificial Intelligence a Reality at the Bedside
- Antibody-Drug Conjugates
- New Immunotherapy Combination Strategies
- Minimal Residual Disease in 2026 and What Is On The Horizon
- Advancing Equitable Oncology in the Asia-Pacific Region – Bridging Gaps With Common Sense
- Case-Based Sessions focused on Liver Cancer, Cervical Cancer, and Oral Cavity Cancers
The Program will also include scientific update sessions, the presentations of new and novel scientific advances, and opportunities for attendees to network and connect with each other to build meaningful partnerships.
Location: Raffles City Convention Centre, Singapore
Key Dates:
Conference dates: 25 – 27 June, 2026
Early registration deadline: 20 May, 2026 at 11:59 PM (ET)